SCHEMBL9517025

SCHEMBL9517025

O=CC(c1cccc(F)c1)S(=O)(=O)NC(=O)c1ccc(CO)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 6/20 0.39
SLC6A9 P48067 1/20 0.38
SLC6A5 Q9Y345 1/20 0.38
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
GRM5 P41594 1/20 0.37
HDAC6 Q9UBN7 2/20 0.36
P4HTM Q9NXG6 2/20 0.36
HDAC4 P56524 2/20 0.36
HDAC7 Q8WUI4 2/20 0.36
HDAC5 Q9UQL6 2/20 0.36
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9516262 0.88 GRM5 (0.40) CASP3SLC6A9SLC6A5GRM5HDAC6
SCHEMBL9518019 0.87 MEN1 (0.39) CASP3MEN1NPC1RAB9AKMT2A
SCHEMBL9517174 0.87 HDAC1 (0.39) CASP3SLC6A9HDAC6HDAC5HDAC3
SCHEMBL9519643 0.87 GRM5 (0.39) CASP3SLC6A9SLC6A5GRM5HDAC6
SCHEMBL9516708 0.86 SLC6A9 (0.37) CASP3SLC6A9SLC6A5MEN1NPC1
SCHEMBL9515545 0.84 HDAC6 (0.36) CASP3SLC6A9SLC6A5MEN1NPC1
SCHEMBL9515835 0.84 LMNA (0.39) CASP3MEN1NPC1RAB9AKMT2A
SCHEMBL9515748 0.83 P4HTM (0.39) CASP3MEN1NPC1RAB9AKMT2A
SCHEMBL9517229 0.82 POLB (0.38) CASP3RAB9AL3MBTL1GRM5HDAC6
SCHEMBL9516974 0.81 EGFR (0.44) CASP3MEN1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed